A Promising Way To Treat Specific Lymphoma.
Researchers have identified a gene departure that may sell a goal for new treatments for a type of lymphoma. The tandem found that a mutation of the MYD88 gene is one of the most frequent genetic abnormalities in patients with this cancer, known as ginormous B cell lymphoma cuatroderm cream. The MYD88 gene encodes a protein that is important for ordinary immune response to invading microorganisms.
The mutation identified in this look at can cause uncontrolled cellular signaling, resulting in the survival of malignant cells. A subgroup of the massive B cell lymphoma that has a dismally moo cure rate - known as the activated B cell-like (ABC) subtype - appears specially impressionable to the gene.
